New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory ...

Lilly’s investigational drug met primary and key secondary endpoints in ATTAIN-2, showing significant weight loss and reduced A1c in people with obesity or overweight and type 2 diabetes.

Eli Lilly said Tuesday it will soon ask global regulators to approve its weight-loss pill following a third successful Phase 3 study.

G et ready to sing! Two new guest stars have been added to Shifting Gears season 2 after it was announced that Tim Allen is ...

At 4:00 p.m. ET (20:00 GMT), the Dow Jones Industrial Average rose 135 points, or 0.3%, while the S&P 500 index climbed 0.4%, ...

The different team produced familiar results for Calhoun, which extended the state’s longest active winning streak to 27 ...

For a growing portion of Johnson County, a new resource offers a place for students and local families to exercise, play and relax. Saints Francis & Clare opened its early childhood ministry ...

Eli Lilly plans to seek regulatory approval for its GLP-1 weight loss pill, Orforglipron, within the year. The latest trial results provide sufficient data for the drugmaker to request global approval ...